Michele Baccarani

1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
   2020/03/03 by Andreas Hochhaus, A. Hochhaus, Michele Baccarani +60 · 9 citations
   Medicine · #Chronic Lymphocytic Leukemia Research #Chronic Myeloid Leukemia Treatments #Eosinophilic Disorders and Syndromes
2. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
   2016/03/04 by William V. Padula, Richard A. Larson, Stacie B. Dusetzina +22 · 26 citations
   Medicine · Social Sciences · Economics, Econometrics and Finance · #Chronic Myeloid Leukemia Treatments #Health, Education, and Cultural Studies #Economic and Financial Impacts of Cancer
3. Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients
   2016/07/23 by David J. Dorer, Ronald K. Knickerbocker, Michele Baccarani +5 · 2 citations
   Medicine · #Acute Lymphoblastic Leukemia research #Chronic Lymphocytic Leukemia Research #Chronic Myeloid Leukemia Treatments